This hypothesis could be tested with expression constructs in which NAGS, CPS1, or citrin promoters and enhancers control reporter gene expression in cell lines that model glioblastoma, glioblastoma multiforme, stomach adenocarcinoma, and stomach and esophagus carcinoma. This evidence concerns the gene SLC25A13 and gastric adenocarcinoma.